查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2012040

术中磁振造影市场：2026-2032年全球市场预测（依磁场强度、扫描器类型、系统类型、应用程式和最终用户划分）

Intraoperative MRI Market by Field Strength, Scanner Type, System Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，术中 MRI 市场价值将达到 20.9 亿美元，到 2026 年将成长至 23.2 亿美元，到 2032 年将达到 48 亿美元，复合年增长率为 12.62%。

主要市场统计数据
基准年 2025 20.9亿美元
预计年份：2026年 23.2亿美元
预测年份 2032 48亿美元
复合年增长率 (%) 12.62%

对术中 MRI 的发展历程、临床驱动因素和整合挑战进行了权威概述，阐述了其在现代外科手术计画中的应用。

术中磁振造影（MRI）已从一种辅助手段转变为不可或缺的工具，重新定义了手术的精准度和手术全期决策。本文概述了临床、技术和组织方面的驱动因素如何共同推动MRI在各个医学专科领域的应用。磁铁设计、影像序列以及与手术流程整合的进步，使医疗团队能够在确认切缘的同时保留病患功能，最大限度地减少再次手术，并降低併发症率。同时，低场硬体的改进、便携性解决方案以及与手术器械的兼容性，正在拓展可应用即时成像技术的手术范围。

技术整合、工作流程整合和临床证据的形成如何从根本上改变术中 MRI 的引入和实践？

术中磁振造影领域正经历一场变革，其驱动力来自于技术创新、不断涌现的临床证据以及医疗服务模式的转变。磁铁工程和影像处理软体的最新进展降低了术中应用的门槛，使得高解析度、高场强解决方案以及可灵活适应各种手术环境的低场强系统成为可能。同时，移动式和固定式系统设计的出现，使得医疗机构能够根据手术量和设施限制调整资本投入。除了这些硬体创新之外，影像序列和术中通讯协定的改进，例如增强组织对比度、减少伪影和缩短撷取时间，也使得术中磁振造影更能适应手术节奏。

2025 年美国关税措施对术中 MRI 专案采购、供应链韧性和业务连续性的连锁反应。

随着全球供应链和贸易政策的演变，美国将于2025年实施的关税政策已成为术中成像解决方案製造商、经销商和医疗系统面临的关键因素。这些关税措施对关键组件的采购决策产生了重大影响，这些组件包括超导性材料、特殊梯度材料以及某些通常在多个司法管辖区生产的电子子系统。为此，供应商被迫重新评估筹资策略，选择替代供应商，并在某些情况下重新设计组件以降低受影响关税项目的风险。因此，供应链的重新检验和双重供应商的采用缩短了生产前置作业时间。

细分市场层面的洞察揭示了磁场强度、扫描器架构、系统便携性、临床应用和最终用户环境如何决定技术选择和临床工作流程。

对系统细分的深入理解有助于明确临床需求与技术能力和采购偏好之间的相互作用。根据磁场强度，系统可分为高场型和低场型。高场型系统具有高固有对比度和空间分辨率，有利于复​​杂的神经外科切除术切除；而低场型系统面积更小，屏蔽要求更低，并且与现有手术室基础设施的兼容性更好。根据扫描仪类型，封闭式和开放式系统之间的差异会影响患者的操作和术中工作效率。封闭式系统通常在头部和某些身体部位的手术中提供稳定的影像质量，而开放式系统则便于手术操作和成像过程中的病患监护。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势和基础设施现状正在塑造术中 MRI 引入的路径和支援模式。

区域趋势对监管路径、采购行为和临床应用模式有显着影响。在美洲，成熟的神经外科中心和综合医疗保健系统，在紧密的转诊网络和集中的研究活动的支持下，推动了复杂脑肿瘤切除术和先进术中通讯协定的早期应用。该地区对模组化服务合约和资金筹措模式的需求也十分旺盛，这些模式能够使资本投资与营运能力和临床结果的预期相匹配。

竞争和服务主导因素正在重塑术中 MRI 生态系统中的供应商策略、整合模式和临床伙伴关係。

竞争格局由少数几家成熟的製造商、新兴的专业供应商以及专注于整合、培训和生命週期支援的服务供应商组成。成熟的技术供应商继续利用其深厚的工程技术专长和临床伙伴关係关係，提供全面的服务包，以扩展模组化、改善影像排序并降低部署和运行过程中的机构风险。同时，新兴的专业参与企业则透过提高灵活性、减少屏蔽要求和简化使用者介面等设计选择来脱颖而出，从而降低手术室团队将术中成像技术整合到日常工作流程中的门槛。

为医疗保健领导者提供实用的操作和策略建议，以优化术中 MRI 技术的选择、实施、培训和结果评估。

产业领导者和医院经营团队可以采取实际行动，确保术中磁振造影技术的成功实施，并最大限度地发挥其临床效益。首先，应让相关人员参与计划规划的早期阶段，明确病例组成、工作流程目标和培训需求，以确保技术选择基于手术实际需求，而非受供应商游说。其次，应优先考虑包含生命週期支援、备件供应和明确服务等级协定 (SLA)的筹资策略，以保障手术安排并确保可预测的正常运作。第三，应考虑混合实施模式，将用于分散式存取的行动系统与用于复杂病例的集中式固定设备相结合，从而优化资金配置和临床覆盖范围。

我们采用透明、以证据为基础的研究途径，整合临床文献、技术文件和相关人员访谈，为决策者提供可操作的见解。

本执行摘要的研究采用综合方法，结合了对同行评审的临床研究、技术白皮书、监管申报文件和供应商产品文件的系统性回顾，并辅以对临床负责人、采购专家和系统整合商的定性访谈。来自多个独立资讯来源的资讯经过交叉检验，建构了关于技术趋势、应用驱动因素和营运挑战的连贯叙述。研究强调长期临床证据和实际部署经验，以确保洞察是基于实际应用，而非单纯的市场标语。

整体结论强调了术中 MRI 计画的临床价值、实施要求和成功所需的操作前提条件。

总之，术中磁振造影在以单阶段根治性手术和最佳组织保留效果为优先目标的外科手术方案中正发挥着日益重要的作用。磁场强度柔软性、扫描器架构和系统便携性方面的技术创新，拓展了术中成像的临床应用范围，并使其更具实用价值。同时，关键专科领域证据的积累，也明确了术中磁振造影能够带来可衡量的临床获益的领域，促使更多医学界领导者将此项技术视为提升外科手术水平的战略投资之一。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 以磁场强度分類的术中磁振造影市场

  • 高磁场
  • 低磁场

第九章：按扫描器类型分類的术中磁振造影市场

  • 封闭式
  • 开孔

第十章：按系统类型分類的术中磁振造影市场

  • 移动系统
  • 静止系统

第十一章 术中磁振造影市场：依应用领域划分

  • 心血管系统
  • 神经外科
    • 开颅手术
    • 脊椎手术
  • 肿瘤学
    • 切片检查指南
    • 肿瘤切除
  • 整形外科

第十二章 术中磁振造影市场：依最终用户划分

  • 门诊手术中心
  • 医院

第十三章 术中磁振造影市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 术中磁振造影市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 术中磁振造影市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国术中磁振造影市场

第十七章 中国术中磁振造影市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Allengers Medical Systems Ltd
  • Aspect Imaging Ltd
  • Aurora Imaging Technology
  • Brainlab AG
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Carl Zeiss AG
  • Esaote SpA
  • FONAR Corporation
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies Inc
  • Hitachi Ltd
  • Hyperfine Inc
  • IMRIS
  • Koninklijke Philips NV
  • Medtronic plc
  • NeuroLogica Corp
  • Neusoft Medical Systems Co Ltd
  • Shenzhen Anke High-Tech Co Ltd
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Stryker Corporation
  • Synaptive Medical
  • Time Medical Systems
  • United Imaging Healthcare Co Ltd
Product Code: MRR-43539E5D2DD1

The Intraoperative MRI Market was valued at USD 2.09 billion in 2025 and is projected to grow to USD 2.32 billion in 2026, with a CAGR of 12.62%, reaching USD 4.80 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.09 billion
Estimated Year [2026] USD 2.32 billion
Forecast Year [2032] USD 4.80 billion
CAGR (%) 12.62%

An authoritative overview of intraoperative MRI evolution, clinical drivers, and integration challenges shaping adoption across modern surgical programs

Intraoperative magnetic resonance imaging has transitioned from a novel adjunct to an integral tool that reshapes surgical precision and perioperative decision-making. This introduction frames the clinical, technological, and organizational drivers that have converged to accelerate adoption across specialty practices. Advances in magnet design, imaging sequences, and integration with surgical workflows are enabling teams to verify resection margins, minimize repeat procedures, and reduce complication rates while preserving function. At the same time, improvements in low-field hardware, mobility solutions, and compatibility with operative instrumentation are widening the spectrum of procedures that can incorporate real-time imaging.

Clinicians, hospital administrators, and device planners are navigating a more complex landscape where clinical efficacy must align with operational constraints and staff competencies. Reimbursement pathways and evidence generation through prospective studies are shaping institutional willingness to invest, while technology vendors are responding with modular systems and service models that emphasize workflow integration and training. Consequently, the narrative of intraoperative MRI is one of pragmatic innovation: technologies are maturing into practical solutions that address demonstrated clinical needs, yet successful deployment requires multidisciplinary alignment, robust change management, and clear measures of patient-centered value.

How technological convergence, workflow integration, and clinical evidence formation are driving a fundamental reshaping of intraoperative MRI adoption and practice

The intraoperative MRI landscape is undergoing transformative shifts driven by converging technological innovation, evolving clinical evidence, and changes in care delivery models. Recent advances in magnet engineering and imaging software have reduced the barriers to intraoperative use, enabling both high-fidelity high-field solutions and flexible low-field systems that can be accommodated in a variety of operating environments. Simultaneously, the emergence of movable and stationary system designs has created options for institutions to align capital investment with procedural volumes and facility constraints. These hardware innovations are complemented by improved imaging sequences and intraoperative protocols that enhance tissue contrast, mitigate artifacts, and shorten acquisition times, thereby making intraoperative MRI more compatible with the tempo of surgery.

Beyond hardware, workflow-centric developments-such as integration with neuronavigation platforms, instrument-tracking technologies, and intraoperative planning tools-are shifting the value proposition from image acquisition alone to comprehensive intraoperative decision support. In parallel, the clinical evidence base for intraoperative MRI, particularly in neurosurgical tumor resection and select orthopedic and oncologic applications, is solidifying. This evidence is catalyzing new care pathways that prioritize single-stage definitive procedures over staged interventions. Finally, the vendor landscape is responding with service models emphasizing training, remote support, and outcome monitoring, which further lowers implementation risk and accelerates clinician confidence in intraoperative MRI.

The ripple effects of United States tariff measures in 2025 on procurement, supply chain resilience, and operational continuity for intraoperative MRI programs

As global supply chains and trade policies evolve, tariff dynamics introduced in the United States in 2025 have become a salient factor for manufacturers, distributors, and health systems involved with intraoperative imaging solutions. These tariff measures have materially affected the sourcing calculus for core components including superconducting materials, specialized gradients, and certain electronic subsystems that are often manufactured across multiple jurisdictions. In response, suppliers have had to reassess procurement strategies, qualify alternative vendors, and in some instances redesign components to mitigate exposure to affected tariff lines. This has resulted in near-term increases in production lead times as supply chains were revalidated and dual-sourcing options were operationalized.

Clinicians and hospital procurement teams have observed the downstream effects as capital procurement cycles adjusted to account for extended lead times and revised delivery schedules. Consequently, institutions have prioritized strategic procurement planning and closer collaboration with vendors to establish guaranteed delivery windows and transparent component sourcing. At the same time, manufacturers have accelerated regionalization and in-country assembly where feasible to minimize tariff sensitivity and provide more resilient delivery commitments. These operational shifts have implications for service contracts and spare-part logistics, prompting health systems to revisit lifecycle support agreements to ensure continuity of care and minimize the risk of equipment downtime during critical surgical periods.

Segment-level insights that reveal how field strength, scanner architecture, system mobility, clinical application, and end-user setting determine technology selection and clinical workflows

A nuanced understanding of system segmentation clarifies where clinical needs intersect with technological capabilities and procurement preferences. Based on Field Strength, systems fall into high-field and low-field categories, with high-field designs delivering higher intrinsic contrast and spatial resolution that benefit complex neurosurgical resections, while low-field platforms offer reduced footprint, simpler shielding requirements, and enhanced compatibility with existing operating room infrastructures. Based on Scanner Type, the distinction between closed bore and open bore systems influences patient access and intraoperative ergonomics, where closed bore units typically provide robust image quality for head and select body procedures and open bore designs facilitate surgical access and patient monitoring during imaging.

Further segmentation by System Type differentiates movable systems from stationary systems, an important operational axis that affects capital allocation, room conversion needs, and scheduling flexibility. Movable systems present a compelling choice for facilities seeking to distribute imaging capability across multiple suites without permanent room conversion, whereas stationary systems are often selected by high-volume centers prioritizing image fidelity and integrated OR design. Based on Application, intraoperative MRI is utilized across cardiovascular, neurosurgery, oncology, and orthopedic procedures, with neurosurgery further categorized into craniotomy and spinal surgery subtypes that reflect divergent imaging and workflow requirements; oncology applications are further distinguished between biopsy guidance and tumor resection, each demanding tailored imaging sequences and intraoperative decision protocols. Finally, based on End User, adoption pathways differ between ambulatory surgical centers and hospitals, with hospitals typically investing in integrated programs that support complex, multidisciplinary cases and ambulatory centers favoring cost-effective, streamlined systems suited to high-throughput elective procedures.

Regional dynamics and infrastructure realities across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape adoption pathways and support models for intraoperative MRI

Regional dynamics influence regulatory pathways, procurement behavior, and clinical adoption patterns in meaningful ways. In the Americas, established centers of neurosurgical excellence and integrated health systems have driven early adoption for complex brain tumor resections and advanced intraoperative protocols, supported by dense referral networks and concentrated research activity. This region also exhibits significant demand for modular service arrangements and financing models that align capital investment with operational throughput and clinical outcomes expectations.

In Europe, the Middle East & Africa, institutional diversity leads to heterogeneous adoption patterns: advanced tertiary centers pursue high-field stationary installations to support cutting-edge neurosurgical programs, while resource-constrained facilities assess lower-field or movable options to balance clinical benefits against infrastructure and staffing considerations. Regulatory harmonization and cross-border clinical collaborations further shape procurement decision cycles and evidence generation efforts. In the Asia-Pacific region, rapid expansion of surgical capacity, progressive hospital modernization, and targeted investments in specialty care drive interest in both movable and fixed solutions, with an emphasis on scalability, service reliability, and local support networks. Across these regions, localized training programs, reimbursement frameworks, and supply chain considerations are pivotal in determining the pace and shape of intraoperative MRI adoption.

Competitive and service-driven forces that are reshaping vendor strategies, integration models, and clinical partnerships in the intraoperative MRI ecosystem

The competitive landscape is defined by a small number of established manufacturers, emerging specialized vendors, and service providers focusing on integration, training, and lifecycle support. Established technology providers continue to leverage deep engineering expertise and clinical partnerships to extend modularity, improve imaging sequences, and offer comprehensive service packages that reduce institutional risk during deployment and operation. At the same time, specialist entrants are differentiating through design choices that emphasize mobility, reduced shielding requirements, and simplified user interfaces that lower the barrier for OR teams to adopt intraoperative imaging into routine workflows.

Service partners and systems integrators play an increasingly important role by offering project management, training, and outcome-monitoring programs that translate product capabilities into reliable clinical performance. Collaboration between vendors and clinical centers has produced standardized protocols and shared datasets that inform procedural best practices, while warranty and remote-support models are evolving to ensure uptime and rapid issue resolution. Importantly, procurement preferences reflect a balance between clinical ambition and operational pragmatism: high-volume centers prioritize image fidelity and throughput, whereas smaller facilities emphasize flexibility, total cost of ownership, and vendor responsiveness. These trends underscore the necessity for vendors to pair strong technical offerings with robust commercial and clinical support capabilities.

Actionable operational and strategic recommendations for healthcare leaders to optimize technology selection, deployment, training, and outcome measurement for intraoperative MRI

Industry leaders and hospital executives can take concrete actions to accelerate successful implementation and maximize clinical benefit from intraoperative MRI. First, align clinical stakeholders early in project planning to define case mix, workflow objectives, and training requirements so that technology selection is driven by procedural needs rather than vendor persuasion. Second, prioritize procurement strategies that incorporate lifecycle support, spare-part availability, and clearly defined service-level agreements to protect operative schedules and ensure predictable uptime. Third, consider hybrid deployment models that pair movable systems for distributed access with a centralized stationary unit for complex cases, thereby optimizing capital allocation and clinical coverage.

Fourth, invest in structured training programs and simulation-based credentialing to shorten the clinician learning curve and embed imaging protocols into routine practice. Fifth, establish outcome-monitoring frameworks that track key clinical indicators such as reoperation rates, procedure times, and patient-centered functional outcomes, and use those data to refine protocols and justify continued investment. Finally, maintain close collaboration with vendors to co-develop incremental improvements in imaging protocols, OR ergonomics, and integration with navigation and surgical planning tools, ensuring that technology evolution remains tightly coupled to clinical priorities and operational constraints.

A transparent, evidence-focused research approach integrating clinical literature, technical documentation, and stakeholder interviews to produce actionable insights for decision-makers

The research synthesis underpinning this executive summary combines a structured review of peer-reviewed clinical studies, technical white papers, regulatory filings, and vendor product documentation, complemented by qualitative interviews with clinical leads, procurement specialists, and systems integrators. Information was triangulated across multiple independent sources to develop a coherent narrative of technological trends, adoption drivers, and operational challenges. Emphasis was placed on longitudinal clinical evidence and real-world deployment experiences to ensure that insights are grounded in practical implementation realities rather than promotional statements.

Analytical rigor was applied to interpret device design attributes, workflow implications, and supply-chain vulnerabilities, with attention to variant use-cases across neurosurgery, oncology, orthopedics, and cardiovascular applications. Careful consideration was given to regional regulatory contexts and procurement practices, and sensitivity was maintained to the interplay between clinical efficacy and operational feasibility. Where direct comparative data were limited, qualitative expert judgment was used to synthesize likely programmatic outcomes, and all conclusions prioritize reproducibility and transparency in the underlying assumptions and data sources.

Synthesized conclusions highlighting the clinical value, implementation imperatives, and operational prerequisites for successful intraoperative MRI programs

In conclusion, intraoperative MRI occupies an increasingly central role in surgical programs that prioritize single-stage definitive interventions and superior tissue-sparing outcomes. Technological innovations in field strength versatility, scanner architecture, and system mobility have expanded the set of clinical settings where intraoperative imaging is practical and beneficial. At the same time, evidence maturation in key specialties has clarified where intraoperative MRI delivers measurable clinical benefits, prompting more healthcare leaders to evaluate this modality as part of strategic investments in surgical excellence.

Implementation success depends on more than device performance: it requires integrated planning across clinical teams, procurement, and service partners, as well as ongoing training and outcome measurement. Supply-chain and trade policy developments necessitate proactive procurement planning and robust vendor partnerships to ensure continuity of service. Ultimately, institutions that thoughtfully align clinical objectives with technology selection, training investments, and outcome monitoring will be best positioned to convert intraoperative MRI capability into demonstrable patient and system value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intraoperative MRI Market, by Field Strength

  • 8.1. High Field
  • 8.2. Low Field

9. Intraoperative MRI Market, by Scanner Type

  • 9.1. Closed Bore
  • 9.2. Open Bore

10. Intraoperative MRI Market, by System Type

  • 10.1. Movable Systems
  • 10.2. Stationary Systems

11. Intraoperative MRI Market, by Application

  • 11.1. Cardiovascular
  • 11.2. Neurosurgery
    • 11.2.1. Craniotomy
    • 11.2.2. Spinal Surgery
  • 11.3. Oncology
    • 11.3.1. Biopsy Guidance
    • 11.3.2. Tumor Resection
  • 11.4. Orthopedic

12. Intraoperative MRI Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals

13. Intraoperative MRI Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Intraoperative MRI Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Intraoperative MRI Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Intraoperative MRI Market

17. China Intraoperative MRI Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Allengers Medical Systems Ltd
  • 18.6. Aspect Imaging Ltd
  • 18.7. Aurora Imaging Technology
  • 18.8. Brainlab AG
  • 18.9. Bruker Corporation
  • 18.10. Canon Medical Systems Corporation
  • 18.11. Carl Zeiss AG
  • 18.12. Esaote S.p.A.
  • 18.13. FONAR Corporation
  • 18.14. FUJIFILM Holdings Corporation
  • 18.15. GE HealthCare Technologies Inc
  • 18.16. Hitachi Ltd
  • 18.17. Hyperfine Inc
  • 18.18. IMRIS
  • 18.19. Koninklijke Philips N.V.
  • 18.20. Medtronic plc
  • 18.21. NeuroLogica Corp
  • 18.22. Neusoft Medical Systems Co Ltd
  • 18.23. Shenzhen Anke High-Tech Co Ltd
  • 18.24. Shimadzu Corporation
  • 18.25. Siemens Healthineers AG
  • 18.26. Stryker Corporation
  • 18.27. Synaptive Medical
  • 18.28. Time Medical Systems
  • 18.29. United Imaging Healthcare Co Ltd

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAOPERATIVE MRI MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INTRAOPERATIVE MRI MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES INTRAOPERATIVE MRI MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA INTRAOPERATIVE MRI MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HIGH FIELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HIGH FIELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HIGH FIELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY LOW FIELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY LOW FIELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY LOW FIELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CLOSED BORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CLOSED BORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CLOSED BORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY OPEN BORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY OPEN BORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY OPEN BORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY MOVABLE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY MOVABLE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY MOVABLE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY STATIONARY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY STATIONARY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY STATIONARY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CRANIOTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CRANIOTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CRANIOTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SPINAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SPINAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SPINAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY BIOPSY GUIDANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY BIOPSY GUIDANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY BIOPSY GUIDANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY TUMOR RESECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY TUMOR RESECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY TUMOR RESECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. GCC INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GCC INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 133. GCC INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. GCC INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. GCC INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. GCC INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 137. GCC INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. GCC INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. G7 INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. G7 INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 157. G7 INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. G7 INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. G7 INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. G7 INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 161. G7 INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. G7 INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. NATO INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. NATO INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 165. NATO INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. NATO INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. NATO INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. NATO INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 169. NATO INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. NATO INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES INTRAOPERATIVE MRI MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA INTRAOPERATIVE MRI MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)